IL10 and neoplasm: For example, premalignant lesions and NSCLC can downregulate interferon signaling to avoid tumor-suppressive inflammation, or secrete inhibitory cytokines like IL-10 that remodel the TME to attract tumor-supporting cells like M2-type macrophages and regulatory T cells [45,46,47].